Thillainayagam Sathiyaseelan

Title: Innovations by Thillainayagam Sathiyaseelan

Introduction

Thillainayagam Sathiyaseelan is an accomplished inventor based in Lexington, MA, with a focus on innovative solutions in the field of immunotherapy. He holds a total of five patents, showcasing his commitment to advancing medical science and addressing critical health challenges.

Latest Patents

One of his notable patents is titled "Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use." This patent describes recombinantly manufactured fusion proteins that include a SARS-CoV-2 Receptor Binding Domain (SARS-CoV-2-RBD) fragment linked to a human Fc fragment. The invention aims to provide therapeutic options for patients affected by COVID-19. It includes various applications, such as using the fusion proteins as a booster vaccination for recovered patients, enabling antibody-naïve patients to produce antibodies, and serving as a prophylactic COVID-19 vaccine. The patent outlines exemplary Fc fusion proteins, pharmaceutical formulations, and methods of use and preparation.

Career Highlights

Thillainayagam has made significant contributions to the field through his work with various companies. He has been associated with Akston Biosciences Corporation and Vakston, Inc., where he has played a pivotal role in developing innovative therapeutic solutions.

Collaborations

Throughout his career, Thillainayagam has collaborated with notable professionals, including Thomas M. Lancaster and Todd C. Zion. These collaborations have further enriched his work and contributed to the advancement of his inventions.

Conclusion

Thillainayagam Sathiyaseelan's innovative work in immunotherapy, particularly in relation to COVID-19, highlights his dedication to improving healthcare outcomes. His patents and collaborations reflect a strong commitment to scientific advancement and the betterment of public health.